Healthcare Providers and Services
Company Overview of Zellera AG
Zellera AG markets and distributes cell therapeutic products for stem cell tissue repair and the treatment of cancer and infectious diseases. The company’s products include AastromReplicell system and Cord Blood (CB)-I and CB-II therapy kits. Zellera is headquartered in Berlin, Germany. The company operates as a wholly owned subsidiary of Aastrom Biosciences, Inc.
49 30 20 65 91 65
49 30 20 65 93 20
Key Executives for Zellera AG
Similar Private Companies By Industry
|Aac Praxisberatung Ag||Europe|
|ACURA Kliniken Baden-Baden GmbH||Europe|
|advita Pflegedienst GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Zellera AG, please visit www.zellera.de. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.